Detalhe da pesquisa
1.
Biological evaluation of 9-thioansamitocin P3.
Biochem Biophys Res Commun
; 696: 149483, 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219484
2.
Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes.
Diabetologia
; 59(8): 1724-31, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27075449
3.
Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
J Pharmacol Exp Ther
; 347(1): 100-16, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23892571
4.
Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion.
Proc Natl Acad Sci U S A
; 107(41): 17791-6, 2010 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20876097
5.
Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II.
Arch Gynecol Obstet
; 288(2): 393-400, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23435724
6.
Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.
Oncologist
; 17(2): 220-32, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22291092
7.
Synthesis of camptothecin-amino acid carbamate linkers.
Amino Acids
; 42(5): 1727-33, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21431932
8.
The antimicrobial peptides and their potential clinical applications.
Am J Transl Res
; 11(7): 3919-3931, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396309
9.
Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
J Pharmacol Exp Ther
; 324(2): 463-74, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18006692
10.
HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II.
Am J Transl Res
; 10(2): 545-553, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29511449
11.
Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships.
Peptides
; 104: 35-40, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29654809
12.
A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
Cancer Lett
; 246(1-2): 157-66, 2007 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16644105
13.
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells.
Peptides
; 28(9): 1883-90, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17580098
14.
Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.
Oncotarget
; 8(14): 23289-23302, 2017 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423575
15.
Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice.
Peptides
; 95: 25-32, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28720396
16.
Somatostatin and its Analogs.
Curr Drug Targets
; 17(5): 529-37, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26951062
17.
Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.
J Drug Target
; 24(2): 169-77, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26211366
18.
Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2.
J Cancer
; 7(11): 1388-95, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27471554
19.
Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats.
Diabetes
; 52(5): 1176-81, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12716749
20.
Gliclazide directly inhibits arginine-induced glucagon release.
Diabetes
; 51 Suppl 3: S381-4, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12475779